Kessler M A, Schuler L A
Department of Comparative Biosciences, University of Wisconsin, Madison.
DNA Cell Biol. 1991 Mar;10(2):93-104. doi: 10.1089/dna.1991.10.93.
Preliminary evidence for heterogeneity among bovine placental lactogen (bPL) transcripts prompted characterization of additional cDNA clones and isolation of the bPL gene. Nucleotide replacements were detected among sequenced cDNAs isolated from different animals at a total of 11 positions. Four of these predict amino acid substitutions, which are generally conservative in nature. In addition, truncated forms of bPL are predicted by the sequences of two cDNAs in which alternative splicing is evident. In one case, exon III is deleted with no effect on reading frame. However, in the other instance, a shifted reading frame resulting in a novel carboxyl terminus is generated by use of an alternative 5' splice donor site within exon IV. Nuclease protection analysis demonstrated that these variant transcripts comprise about 13% of the total bPL mRNA present in the midgestation placenta. Characterization of the bPL gene revealed that it is similar in structure to other members of this gene family. Sequence analysis demonstrated that the 5'-flanking region of the bPL gene has diverged considerably from the bovine prolactin and growth hormone genes, but shares homology with the previously characterized gene corresponding to bovine prolactin-related cDNAI (bPRCI). Primer extension as well as nuclease protection analysis indicated that a single transcription start site was utilized in the fetal placenta at midgestation. Exact matches to the consensus sequences for response elements for thyroid hormone and transcription factor AP-2 were located 50 and 70 bp, respectively, upstream from the transcription start site in cloned genomic 5'-flanking sequences. We conclude that the bovine placenta may express more than a single placental lactogen product, raising the possibility of alternative hormones with distinct biological properties, and that the bPL gene may share regulatory elements with the gene for the distinct prolactin-related product, bPRCI, based on similarities in the 5' regions of the corresponding genes.
牛胎盘催乳素(bPL)转录本存在异质性的初步证据促使人们对更多的cDNA克隆进行表征,并分离出bPL基因。在从不同动物分离得到的已测序cDNA中,总共在11个位置检测到核苷酸替换。其中四个预测会发生氨基酸替换,这些替换在本质上通常是保守的。此外,两个cDNA的序列预测出bPL的截短形式,其中明显存在可变剪接。在一种情况下,外显子III缺失,对阅读框没有影响。然而,在另一种情况下,通过使用外显子IV内的一个替代5'剪接供体位点,产生了一个导致新的羧基末端的移码阅读框。核酸酶保护分析表明,这些变异转录本约占妊娠中期胎盘内总bPL mRNA的13%。bPL基因的表征显示,其结构与该基因家族的其他成员相似。序列分析表明,bPL基因的5'侧翼区域与牛催乳素和生长激素基因有很大差异,但与先前表征的对应于牛催乳素相关cDNAI(bPRCI)的基因具有同源性。引物延伸以及核酸酶保护分析表明,妊娠中期胎儿胎盘中使用了单个转录起始位点。在克隆的基因组5'侧翼序列中,甲状腺激素反应元件和转录因子AP - 2的共有序列的精确匹配分别位于转录起始位点上游50和70 bp处。我们得出结论,牛胎盘可能表达不止一种胎盘催乳素产物,这增加了存在具有不同生物学特性的替代激素的可能性,并且基于相应基因5'区域的相似性,bPL基因可能与不同的催乳素相关产物bPRCI的基因共享调控元件。